The grey market premium of the Avience Biomedicals IPO, day by day, against the ₹208 upper price band. Last figure from 25 Jun 2026.
The GMP of the Avience Biomedicals IPO started at ₹0 on 13 Jun 2026 and ended ₹145 before listing, up ₹145 over 13 days.
It peaked at ₹145 on 24 Jun 2026 and was lowest at ₹0 on 13 Jun 2026. In the last 4 days it rose by ₹73.
From one recorded day to the next, the GMP rose on 6 days, fell on 2 days and held on 4 days. The largest one-day move was a rise of ₹70 on 15 Jun 2026.
On the day bidding opened, 18 Jun 2026, the GMP was ₹85; on the day it closed, 22 Jun 2026, it was ₹72.
Bidding closed with the issue subscribed 385.32× overall.
At the ₹208 upper band, the last GMP pointed to a 69.71% gain; the shares listed up 90%, so the GMP understated the gain.
One lot is 600 shares, ₹1,24,800 at the ₹208 upper band. On this SME issue an individual applies for at least 2 lots, ₹2,49,600.
The last GMP pointed to a gain of ₹87,000 on one lot. The shares listed at about ₹395.2, which made a gain of ₹1,12,320 on one lot.
At the highest GMP, ₹145, the figure for one lot was a gain of ₹87,000; at the lowest, ₹0, it was no gain.
GMP last updated: 25 Jun 2026, 9:36 AM IST
| Date | GMP | Over issue price | Implied listing | Change |
|---|---|---|---|---|
| 25 Jun 2026 | ₹145 | 69.71% | ₹353 | – |
| 24 Jun 2026 | ₹145 | 69.71% | ₹353 | +₹50 |
| 23 Jun 2026 | ₹95 | 45.67% | ₹303 | +₹23 |
| 22 Jun 2026 | ₹72 | 34.62% | ₹280 | +₹2 |
| 21 Jun 2026 | ₹70 | 33.65% | ₹278 | −₹15 |
| 20 Jun 2026 | ₹85 | 40.87% | ₹293 | – |
| 19 Jun 2026 | ₹85 | 40.87% | ₹293 | – |
| 18 Jun 2026 | ₹85 | 40.87% | ₹293 | +₹10 |
| 17 Jun 2026 | ₹75 | 36.06% | ₹283 | +₹12 |
| 16 Jun 2026 | ₹63 | 30.29% | ₹271 | −₹7 |
| 15 Jun 2026 | ₹70 | 33.65% | ₹278 | +₹70 |
| 14 Jun 2026 | ₹0 | 0% | ₹208 | – |
| 13 Jun 2026 | ₹0 | 0% | ₹208 | – |
GMP is an unofficial price from the grey market before the shares list. It is not a guarantee of the listing price and can move sharply from one day to the next. Read how we collect it in our methodology.